The first XR Research Awards received great interest with 319 applications and 89 proposals. The XRRA provided a new opportunity for researchers and content creators to apply to a €50,000 fund to study behaviour in VR and promote the use of objective data to understand human behavioural responses in VR.

Entrants Can Submit Nominations in the Top Sales and Customer Service Awards Through February 2 Stevie Awards for Sales & -Service FAIRFAX, Va., Jan. 13, 2022 (GLOBE NEWSWIRE) — By popular demand, the Stevie® Awards have extended the final entry deadline in the 16th annual Stevie® Awards for Sales &

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced that it has originated a $345 million loan to Cronin Development for the completion of a 22-story, 114-unit residential and retail condominium

Milestone follows recent announcement of STACK’s entrance to APAC market with the opening of its Singapore regional headquarters DENVER, SINGAPORE and TOKYO, Jan. 13, 2022 (GLOBE NEWSWIRE) — STACK Infrastructure (“STACK” or the “Company”), the digital infrastructure partner to the world’s most innovative companies, today announced a partnership with funds

HAS Healthcare Advanced Synthesis launches as an independent business Biasca, Switzerland, January 13, 2022 – HAS Healthcare Advanced Synthesis SA (the “Company”), a full-service contract development and manufacturing organization (CDMO) delivering high-quality, exclusive, personalized solutions to its healthcare clients, today announces its launch as an independent business. Originally established as

Manchester United Head of Academy Highlights Importance of Individuality and Confidence for Young Players Remington Extends Partnership with Manchester United MANCHESTER, England, Jan. 13, 2022 (GLOBE NEWSWIRE) — Spectrum Brands Holdings, Inc. (NYSE: SPB) and Manchester United (NYSE: MANU) jointly announced today the extension of their global partnership, which will

Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron Multiple Efforts Underway to Address Omicron and Potential Future SARS-CoV-2 Variants WALTHAM, Mass., Jan. 12, 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company